-
Abstract Number: 1799
Wellness and Resiliency Among Recent Rheumatology Fellowship Graduates: A Qualitative Study
-
Abstract Number: 1800
Safety and Humoral Immunogenicity to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis (interim Analysis)
-
Abstract Number: 1801
Comparison of Infection-Related Hospitalization Risk and Cost in TNFi-Experienced Medicare Beneficiaries with Rheumatoid Arthritis Treated with Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs
-
Abstract Number: 1802
Utility of Repeat Latent Tuberculosis Testing in Patients Taking Biologics
-
Abstract Number: 1803
Performance of the RABBIT Infection Score in a Prospective Multicenter Cohort of Rheumatoid Arthritis Patients from Argentina
-
Abstract Number: 1804
Safety of the Zoster Vaccine Recombinant, Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center’s Experience with 400 Patients
-
Abstract Number: 1805
Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study
-
Abstract Number: 1806
Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy: A Distinct Clinical Entity and Immunologic Phenotype
-
Abstract Number: 1807
Teprotumumab, a Novel Biologic for Active Thyroid Eye Disease
-
Abstract Number: 1808
Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation
-
Abstract Number: 1809
A Quarter of Patients Treated with Checkpoint Inhibitors Develop Immune-Related Adverse Events: A University Center Experience
-
Abstract Number: 1810
Rheumatic Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Retrospective, Pharmacovigilance Study
-
Abstract Number: 1811
Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint Inhibitors
-
Abstract Number: 1812
Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis
-
Abstract Number: 1813
New Medications Are Needed for Children with Juvenile Idiopathic Arthritis
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 198
- Next Page »